PharmGen Science, Inc. (004720.KS) KSC
3,080.00
-80(-2.53%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 91.22B |
| Enterprise Value | 75.34B |
| P/E Ratio | -0.58 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.32 |
| Price/Book Ratio | 0.45 |
| Enterprise/Revenue | 0.25 |
| Enterprise/EBITDA | 4.58 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.67 |
| Operating Margin | 0.03 |
Management Effectiveness
| Return On Assets | -0.59 |
| Return On Equity | -0.59 |
Income Statement
| Revenue | 173.07B |
| Revenue/Share | 7,918.64 |
| Gross Profit | 109.13B |
| EBITDA | 10.53B |
| Net Income | -116.64B |
| Diluted EPS | -5,312.85 |
Balance Sheet
| Total Cash | 18.94B |
| Total Cash/Share | 864.31 |
| Total Debt | 6.14B |
| Total Debt/Equity | 0.04 |
| Current Ratio | 2.9 |
| Book Value Per Share | 6,861.9 |
Price History
| 52-Week Change | -29.44 |
| 52-Week High | 5,490 |
| 52-Week Low | 3,010 |
| Moving Average 50 Days | 3,773.4 |
| Moving Average 200 Days | 4,073.53 |
Statistics
| Average Volume | 91,208 |
| Shares Outstanding | 18.16M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | December 09, 2014 |
